Grants per year
Personal profile
Education/Academic qualification
Immunobiology, PhD, Iowa State University
… → 2012
Medicine, MD, Southeast University School of Medicine
… → 2001
Fingerprint
Dive into the research topics where Lijie Zhai is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 1 Active
-
IDO1 and Immunotolerance in Glioblastoma
Wainwright, D. A., Horbinski, C. M., Lukas, R. V. & Zhai, L.
National Institute of Neurological Disorders and Stroke
6/1/21 → 6/30/27
Project: Research project
-
Multi-class cardiovascular disease detection and classification from 12-lead ECG signals using an inception residual network
Ni, J., Jiang, Y., Zhai, S., Chen, Y., Li, S., Amei, A., Tran, D. M. T., Zhai, L. & Kuang, Y., Jul 2021, Proceedings - 2021 IEEE 45th Annual Computers, Software, and Applications Conference, COMPSAC 2021. Chan, W. K., Claycomb, B., Takakura, H., Yang, J-J., Teranishi, Y., Towey, D., Segura, S., Shahriar, H., Reisman, S. & Ahamed, S. I. (eds.). Institute of Electrical and Electronics Engineers Inc., p. 1532-1537 6 p. (Proceedings - 2021 IEEE 45th Annual Computers, Software, and Applications Conference, COMPSAC 2021).Research output: Chapter in Book/Report/Conference proceeding › Conference contribution
-
Tumor Cell IDO Enhances Immune Suppression and Decreases Survival Independent of Tryptophan Metabolism in Glioblastoma
Zhai, L., Bell, A., Ladomersky, E., Lauing, K. L., Bollu, L., Nguyen, B., Genet, M., Kim, M., Chen, P., Mi, X., Wu, J. D., Schipma, M. J., Wray, B., Griffiths, J., Unwi, R. D., Clark, S. J., Acharya, R., Bao, R., Horbinski, C., Lukas, R. V. & 2 others, , Dec 1 2021, In: Clinical Cancer Research. 27, 23, p. 6514-6528 15 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with Glioblastoma
Ladomersky, E., Zhai, L., Lauing, K. L., Bell, A., Xu, J., Kocherginsky, M., Zhang, B., Wu, J. D., Podojil, J. R., Platanias, L. C., Mochizuki, A. Y., Prins, R. M., Kumthekar, P., Raizer, J. J., Dixit, K., Lukas, R. V., Horbinski, C., Wei, M., Zhou, C., Pawelec, G. & 5 others, , Oct 1 2020, In: Clinical Cancer Research. 26, 19, p. 5232-5245 14 p.Research output: Contribution to journal › Article › peer-review
Open Access18 Scopus citations -
Immunosuppressive IDO in Cancer: Mechanisms of Action, Animal Models, and Targeting Strategies
Zhai, L., Bell, A., Ladomersky, E., Lauing, K. L., Bollu, L., Sosman, J. A., Zhang, B., Wu, J. D., Miller, S. D., Meeks, J. J., Lukas, R. V., Wyatt, E., Doglio, L., Schiltz, G. E., McCusker, R. H. & Wainwright, D. A., Jun 16 2020, In: Frontiers in immunology. 11, 1185.Research output: Contribution to journal › Review article › peer-review
Open Access36 Scopus citations -
Commentary: preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma by Garg et al. (2017)
Zhai, L., Ladomersky, E., Lauing, K. L., Wu, M., Scholtens, D. M., Savoor, R., Zhang, B., Wu, J. D., Horbinski, C., Lukas, R. V., Binder, D. C. & Wainwright, D. A., Mar 4 2019, In: OncoImmunology. 8, 3, 1548242.Research output: Contribution to journal › Comment/debate › peer-review